CURRENT MEDICAL RESEARCH AND OPINION, cilt.23, sa.5, ss.1093-1102, 2007 (SCI-Expanded)
Objective:The efficacy and safety of extended-release fluvastatin (fluvastatin XL), 80 mg once daily, was assessed in Turkish patients with primary hypercholesterolaemia (low-density lipoprotein cholesterol (LDL-C) 3.37-5.70 mmol/l and triglyceride (TG) < 4.52 mmol/l).